Envista Holdings Corporation (NVST)
Stock Price Chart
Key Info
| Market Cap | 3.94B |
| Revenue (ttm) | 2.29B |
| Net Income (ttm) | 7.50M |
| Shares Out | 159.22M |
| EPS (ttm) | 1.60 |
| PE Ratio | 15.45 |
| Forward PE | 28.09 |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Oct 28, 2020 |
| Last Price | $24.72 |
| Previous Close | $26.05 |
| Change ($) | -1.34 |
| Change (%) | -5.12% |
| Day's Open | 25.54 |
| Day's Range | 24.57 - 25.72 |
| Day's Volume | 351,768 |
| 52-Week Range | 10.08 - 33.30 |
More Stats
| Market Cap | 3.94B |
| Enterprise Value | 5.29B |
| Earnings Date (est) | Oct 29, 2020 |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 159.22M |
| Float | 158.33M |
| EPS (basic) | 0.13 |
| EPS (diluted) | 1.60 |
| FCF / Share | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | 6.47% |
| FCF Yield | n/a |
| Payout Ratio | n/a |
| Shares Short | 11.17M |
| Short Ratio | 7.59 |
| Short % of Float | 7.06% |
| Beta | n/a |
| PE Ratio | 15.45 |
| Forward PE | 28.09 |
| P/FCF Ratio | n/a |
| PS Ratio | 1.72 |
| PB Ratio | 1.26 |
| Revenue | 2.29B |
| Operating Income | 23.80M |
| Net Income | 7.50M |
| Free Cash Flow | n/a |
| Net Cash | -1.36B |
| Net Cash / Share | -8.51 |
| Gross Margin | 66.23% |
| Operating Margin | 1.04% |
| Profit Margin | 0.30% |
| FCF Margin | n/a |
| ROA | 1.01% |
| ROE | 0.18% |
| ROIC | 1.10% |
Analyst Forecasts
Analyst Consensus: Buy
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|
| Revenue | 2,752 | 2,845 | 2,811 | 2,785 |
| Revenue Growth | -3.27% | 1.2% | 0.92% | - |
| Gross Profit | 1,513 | 1,602 | 1,621 | 1,601 |
| Operating Income | 278 | 298 | 387 | 403 |
| Net Income | 218 | 231 | 301 | 272 |
| Shares Outstanding | 136 | 128 | 128 | - |
| Earnings Per Share | 1.60 | 1.80 | 2.35 | - |
| EPS Growth | -11.11% | -23.4% | - | - |
| Operating Cash Flow | 398 | 400 | 359 | 417 |
| Capital Expenditures | -76.20 | -72.20 | -48.80 | -48.20 |
| Free Cash Flow | 321 | 328 | 310 | 369 |
| Cash & Equivalents | 211 | - | - | - |
| Total Debt | 1,538 | - | - | - |
| Net Cash / Debt | -1,326 | - | - | - |
| Assets | 6,158 | 5,842 | 5,993 | - |
| Liabilities | 2,616 | 1,015 | 998 | - |
| Book Value | 3,540 | 4,823 | 4,991 | - |
Company Profile
Company Details
| Full Name | Envista Holdings Corporation |
| Country | United States |
| Employees | 12,500 |
| CEO | Amir A. Aghdaei |
Stock Information
| Ticker Symbol | NVST |
| Stock Exchange | New York Stock Exchange |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Unique Identifier | NYSE: NVST |
| IPO Date | September 18, 2019 |
Description
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures and markets dental products in the United States and internationally. The company operates in two segment, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare systems, Alpha Bio Tec, Implant Direct, Nobel Procera, and Orascoptic; and brackets and wires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Ormco, Insignia, AOA, and Spark brands. This segment also offers software packages used for the treatment planning of dental implants and prosthetics. The company's Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; handpieces and associated consumables; treatment units and other dental practice equipment; endodontic systems and related consumables; and restorative materials and instruments, rotary burs, impression materials, bonding agents and cements, and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, KaVo, Pelton & Crane, Kerr, MetrexTM, Sybron Endo, Total Care, and Pentron brands to dental offices, clinics, and hospitals. The company was incorporated in 2018 and is headquartered in Brea, California.